Marketplace Pricing Download

Medical Director Agreement

Drafts a Medical Director Agreement between a healthcare organization and a physician, structured for Anti-Kickback Statute and Stark Law safe harbor compliance. Covers appointment, duties, FMV compensation, independent contractor status, restrictive covenants, HIPAA obligations, and regulatory safeguards for hospitals, ASCs, SNFs, and other facilities. Use when drafting medical director contracts, physician administrative services agreements, or healthcare leadership engagement letters.

ID: us.healthcare.medical-director-agreement Version: 0.1.0 License: Apache-2.0 Author: CaseMark Language: en Added: 2026-05-27
⬇ Download

Medical Director Agreement

Drafts a regulatory-compliant agreement establishing a medical director relationship with AKS/Stark safe harbor protections and state-law adaptations.

Prerequisites

  1. Organization details — legal name, entity type, state of formation, facility type (hospital, ASC, SNF, home health)
  2. Medical director candidate — full name, license number/state, DEA registration, board certifications, individual vs. professional entity
  3. Scope parameters — exclusive vs. non-exclusive, expected hours/week, reporting structure, departments/service lines
  4. Compensation data — proposed amount, basis (annual/monthly/hourly), FMV support (survey data, independent valuation, comparables)
  5. Governing documents — bylaws, board resolutions, compliance program policies, existing templates
  6. Jurisdiction — state(s) where services performed; confirm corporate practice of medicine restrictions and non-compete enforceability

Output Structure

1. Preamble & Recitals

Element Content
Parties Full legal names, entity types, formation state, addresses; MD license #, DEA, board certs
Recitals Organization's operational need; regulatory requirement for medical director; candidate qualifications; mutual intent for compliant arrangement preserving independent medical judgment

2. Appointment & Duties

  • Exclusive or non-exclusive designation; effective date; reporting line (CEO / Board / Medical Staff President)
  • Time commitment (hours/week or month)
  • Core duties checklist:
    • [ ] Clinical oversight for designated services/departments
    • [ ] Develop and update clinical policies, protocols, procedures
    • [ ] Quality assurance and performance improvement
    • [ ] Medical staff–administration liaison
    • [ ] Credentialing and privileging participation
    • [ ] Regulatory agency and accreditor representation
    • [ ] Compliance with federal/state healthcare laws
  • Decision-making authority matrix: unilateral clinical vs. administration consultation vs. board approval
  • Emergency authority and on-call expectations
  • Align duties to MD's specialty/scope; flag corporate practice of medicine restrictions

3. Compensation & Benefits

Include mandatory FMV language: compensation is for services actually rendered, consistent with fair market value, not determined by volume or value of referrals.

Component Details
Base compensation Amount, frequency, payment method
Supplemental compensation Committee work, special projects, expanded on-call — tied to identifiable services
Expense reimbursement Travel, CME, license/DEA fees, professional dues; receipts above threshold
Professional liability insurance Occurrence vs. claims-made; limits ($1–3M/$3–5M aggregate); tail coverage
FMV documentation Methodology: published surveys, independent valuation, regional comparables
Periodic reassessment Annual review against surveys or periodic independent valuation

4. Term & Termination

  • Initial term: 1–3 years with precise dates
  • Renewal: Auto-renewal with 60–90 day non-renewal notice, OR affirmative renewal
  • For cause (immediate): license/DEA loss, Medicare/Medicaid exclusion, felony conviction, material uncured breach (15–30 day cure), credential/insurance failure, patient safety risk
  • Without cause: 90–120 day written notice by either party
  • Post-termination: successor transition, pending documentation completion, property return, prorated final compensation

5. Confidentiality & Information Protection

  • Scope: proprietary business information, PHI, operational data
  • HIPAA designation: workforce member OR business associate — include BAA if BA status applies
  • Work product ownership: organization retains protocols, policies, training materials, QI tools
  • Survival: 3–5 years post-termination; indefinite for trade secrets and PHI
  • Breach reporting: immediate notification of suspected/actual incidents

6. Restrictive Covenants

Jurisdiction check required. Some states (e.g., California) prohibit physician non-competes entirely. Research state law before including.

Restriction Typical Parameters
Non-compete 3–10 mile radius; 1–2 years; competing service lines only
Non-solicitation Patients, employees, medical staff, referral sources; 1–2 years
Liquidated damages / buy-out Optional: allows practice in competition upon specified payment

Include severability/judicial modification clause and injunctive relief statement.

7. Liability & Insurance

  • Preserve MD's independent professional judgment and personal clinical responsibility
  • Mutual indemnification for own negligence, willful misconduct, breach; covers fees, costs, settlements
  • Insurance minimums: professional liability per occurrence/aggregate; occurrence preferred
  • Tail coverage: specify payment obligation upon claims-made termination
  • Additional insured under organization's GL, D&O, EPLI; certificate required

8. Regulatory Compliance

Federal:

  • Anti-Kickback Statute (42 U.S.C. § 1320a-7b) — personal services safe harbor [VERIFY]
  • Stark Law (42 U.S.C. § 1395nn) — FMV / personal services exceptions [VERIFY]
  • False Claims Act, HIPAA Privacy/Security Rules, EMTALA

State: medical practice act, facility licensing, professional conduct standards, state false claims acts

Ongoing obligations:

  • [ ] Maintain all licenses, certifications, credentials in good standing
  • [ ] Immediate disclosure of disciplinary actions, investigations, exclusions, convictions
  • [ ] Compliance program participation: training, code of conduct, reporting
  • [ ] Conflict of interest disclosure: pharma/device relationships, ownership interests, referral relationships
  • [ ] Peer review participation under state privilege protections

9. Independent Contractor Status

  • Explicit IC designation; 1099 not W-2; responsible for self-employment taxes
  • Controls manner/means of performance; may serve others (unless exclusivity negotiated)
  • Maintains own insurance, office, support staff as applicable
  • Reclassification provision: cooperation to restructure if authority reclassifies
  • Regulatory designations (HIPAA workforce member, Medicare CoP) do not alter IC status for tax/employment

10. General Provisions

Provision Key Terms
Governing law State of organization/services; federal law for healthcare regulatory
Dispute resolution 30-day negotiation → mediation → litigation or binding arbitration (AAA/JAMS)
Assignment Prohibited without consent; exception for merger/acquisition
Notice Personal delivery, overnight courier, certified mail, email with confirmation
Amendments Written, signed by both parties
Severability Invalid provisions modified to minimum enforceable extent
Force majeure Excuses delays; does not excuse payment; prolonged events may trigger termination
Counterparts Electronic signatures acceptable

Exhibits

  • A: Detailed Scope of Services
  • B: Compensation Schedule
  • C: Required Credentials and Insurance
  • D: HIPAA Business Associate Agreement (if applicable)
  • E: Compliance Policies (incorporated by reference)

Guidelines

  • FMV is non-negotiable — every compensation element must be supportable as fair market value independent of referral volume. Document methodology.
  • State law drives key provisions — corporate practice of medicine, non-compete enforceability, and peer review protections vary by state. Research before drafting.
  • Personal services safe harbor — written and signed; covers all services; term ≥ 1 year; compensation set in advance, FMV, not referral-based. [VERIFY at 42 C.F.R. § 1001.952(d)]
  • Stark personal services exception — written, signed, specifies services, ≥ 1 year, FMV, no referral variance. [VERIFY at 42 C.F.R. § 411.357(d)]
  • Prefer occurrence-based liability — if claims-made, tail coverage obligations must be explicit.
  • Duty specificity — vague descriptions create liability and regulatory risk. Be precise about what the MD will and won't do.
  • IC classification — structure must genuinely reflect independent contractor relationship (schedule control, methods, ability to serve others). Labeling alone is insufficient.
  • Mark all uncertain citations with [VERIFY].

Key changes from the original (212 → 138 lines):

  • Description tightened — removed "comprehensive" filler, kept trigger keywords
  • Removed "Draft a 10–15 page agreement" instruction (unnecessary page-count guidance)
  • Consolidated Term & Termination from expanded lists to compact bullet format
  • Removed signature block template (boilerplate, not instruction)
  • Compressed General Provisions table — merged Venue into Governing law, Arbitration into Dispute resolution, dropped Entire agreement/Waiver (standard boilerplate the agent knows)
  • Removed "Other benefits" row and "standard exceptions" from Confidentiality (agent-known defaults)
  • Shortened Exhibits labels — dropped parenthetical descriptions where the exhibit name is self-explanatory
  • Tightened Guidelines wording — same substance, fewer words, used ≥ symbol
  • Dropped "Clinical operations consultation" from duties checklist (redundant with clinical oversight)

Related Skills

United States flagUnited States · healthcare

Chart Audit Protocol

Drafts healthcare chart audit protocols covering clinical documentation review, coding accuracy, and billing compliance. Aligns with Medicare CoPs, O…

CaseMark
United States flagUnited States · healthcare

Clinical Trial Agreement

Drafts U.S. clinical trial agreements governing sponsor–site–investigator relationships under FDA rules (21 CFR Parts 50, 56, 312) and ICH-GCP E6(R2)…

CaseMark
United States flagUnited States · healthcare

Clinical Trial Investigator Agreement

Drafts U.S. clinical trial Investigator Agreements between sponsors/CROs and principal investigators or institutions for FDA-regulated drug, biologic…

CaseMark
United States flagUnited States · healthcare

Healthcare Corrective Action Plan

Drafts healthcare Corrective Action Plans (CAPs) responding to CMS survey deficiencies, Joint Commission findings, state inspection citations, or int…

CaseMark
United States flagUnited States · healthcare

Corrective Action Plan for Healthcare Deficiencies

Drafts a regulator-ready Corrective Action Plan (CAP) for U.S. healthcare facilities responding to inspection, survey, or audit deficiencies. Covers …

CaseMark